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Improved Cardiac Function Using Cardioplegia During 
Procurement and Transplantation 
R. L. Hardesty, B. P. Griffith, G. M. Deeb, H. T. Bahn~onI and T. E. Starzl 
CARDIAC transplantation was resumed 
as a therapeutic procedure at the Uni-
versity of Pittsburgh in June of 1980. Distant 
procurement and a simple preservation tech-
nique can be used to preserve donor hearts for 
3-4 hr with satisfactory function of the graft.! 
In this report. we describe a technique using 
cardioplegia, which improves preservation 
during implantation. 
MATERIALS AND METHODS 
Our use of cardioplegia during cardiectomy and 
implantation has vaned. In 10 instances. none was used 
during excision nor during implantation. in 3 it was 
infused only during cardiectomy, and in 16. both during 
excision and implantation. "'Stanford solution'" (Table 1) 
has been used during cardiectomy and "'Buckberg blood 
cardioplegia",2 (Table 2) during implantation. 
Heart, liver. and kidneys. all functionally satisfactory 
for grafting, have been obtained from 10 donors. The 
donor's temperature ambiently cools to 33-34°C and in 
situ cooling of the liver, achieved by infusing lactated 
Ringer's solution (4°C) into the portal vein. further cools 
the heart. An initial sternotomy and celiotomy provide 
access for a rapid cardiectomy should the hepatectom~ 
and nephrectomy compromise cardiac function, but this 
has never occurred. In situ cooling of kidneys is preferred. 
and the infusion is begun immediately after occlusion of 
the ascending aorta initiates c;:rdlectomy. The liver and 
kidneys are excised su bsequent to removal of the heart. 
Ex vivo cooling of kidneys necessitates interruption of 
venous return and results in hemodynamic instability. 
Although not preferable, it has been accomplished in 
order to comply with the hosting institution's wishes. 
The superior vena cava is stapled. the inferior cava 
occluded and divided, the aorta ocduded and cardioplegia 
infused. the pulmonary veins and pulmonary arteries 
transected, and lastly the aorta divided. Cardioplegia is 
infused into the aorta through a 12-gauge catheter at a 
maximal pressure of 150 mm Hg. The infusion is facili-
tated by promptly transecting a pulmonary vein and 
eliminating return to the left atrium and ventricle. 
A novel technique of stapling the divided aorta of the 
donor heart with the Ravitch TIA 30 stapler (3.5 mm or 
V staples) (American Surgical Instruments. Inc.) enables 
cardioplegia to be infused into the donor heart during 
implantation (Fig. I). The 12-gauge catheter used during 
cardiectomy is affixed to the donor's aona with a purse-
string suture at that time and left in place. During 
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infusion, air is evacuated by placing an IS-gauge needle 
into the segment of aorta between the aortic valve and 
staple line. The solution is infused every 20 min at a 
pressure of 120 mm Hg by employing a constant pressure-
variable flow pump. External cooling every 20 min (4°C 
crystalloid solution) and internal cooling upon completion 
of the atrial anastomoses via the left atrial appendage was 
employed in every transplantation. 
The need for inotropic drugs (dopamine and/or dobut-
amine) was ascertained retrospectively according to the 
number of days (>12 hr - I day) dopamine and/or 
dobutamine was used in excess of 10 ltg/kg/min to 
maintain a normal mean arterial pressure (60-80 mm 
Hg) and urinary output (>30 cc/hr). 
RESULTS 
When no cardioplegia (10 patients) was 
used during cardiectomy or implantation, 
dopamine and/or dobutamine were used for 
2.8 days, whereas when cardioplegia was used 
during cardiectomy and also during implanta-
tion (16 patients), these drugs were used for 
0.1 days-a difference that is statistically 
significant (p < 0.001). The total ischemic 
times were not statistically different (p > 
0.05) (Fig. 2). The times of transportation and 
implantation are detailed in Fig. 3. 
DISCUSSION 
Our initial concept was that rapid excision 
of the donor heart and immersion in a crystal-
loid solution at 4°C was simpler and would 
quickly cool and arrest the heart so that the 
fundamental principles of preservation would 
be met.3 The postoperative need for inotropic 
support in these patients suggested that this 
was not correct, and subsequent laboratory 
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Table 1. Stanford Cardioplegic Solution 
Component 
Potassium 
Sodium 
Chloride 
Bicarbonate 
Dextrose 
Mannitol 
Osmolality 
pH (at 4° C) 
Concentration 
30 meq!liter 
25 meq/liter 
30 meq/liter 
25' meq/liter 
50 g/Iiter 
1 2.5 g/Iiter 
440 mosmole/liter 
8.1-8.4 
Table 2. Buckberg Blood Cardioplegia 
Component 
knic calcium 
KC1 
Osmolanty 
Het 
pH 
Concentration 
0.6 meq/liter 
30 meq/liter 
355 mOsmole 
20 
7.7 
evidence contradicted this concept. In dogs, 
the septal temperature decreased more rap-
idly and arrest occurred sooner (Fig. 4) when 
cardioplegia was used during the cardiecto-
my. Not compared in this report were three 
transplants in which cardioplegia was used 
during excision of the donor heart but not 
during implantation. The lesser need for ino-
tropic support was readily evident (retrospec-
tively 0.5 days of dopamine and/or dobut-
amine at > 10 ~g/kg/min compared to 2.8 
Fig. 1. Technique of infusing cardioplegia into the 
donor heart during implantation. 
150 
en 
w 
'; 100 
z 
::::;: 
50 
0 
HARDES1Y ET AL. 
MYOCARDIAL PRESERVATION 
p>.05 
~ 
151 
TOTAL 
ISCHEMIA 
~kl 
• CAROIOPL£GIA 
3.0 
2.5 
en ,.. 2.0 
« 
c 
1.5 
1.0 
.5 
p<.OOI 
2.8 
DOPAMINE 
OOBUTAMINE 
>1 0!'91 kq/m in 
Fig. 2. When no cardioplegia (10 patients) was 
used during cardiectomy or implantation. dopamine 
and I or dobutamine were used for 2.B days, whereas 
when cardioplegia was used during cardiectomy and 
also during implamation (16 patients), the.e drugs were 
used for 0.1 days-a difference that is statistically 
significant (p < 0.0011. The total ischemic times were 
not statistically different (p > 0.051. 
days without it). Concurrently, the idea of 
stapling the donor aorta in order to facilitate 
the use of cardioplegia during implantation 
originated and was combined with the latter. 
The benefits to the donor heart include main-
tenance of arrest and hypothermia and 
washout of metabolites. The early benefit to 
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Fig. 3. The total ischemic times ware not statisti-
cally different. The times of transportation and implan-
tation are statistically significantly diffarent. 
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the recipient is a lesser need for cardiotonic 
support postoperatively. 
SUMMARY 
More rapid cooling and early arrest of a 
donor heart can be achieved with the use of 
c:ardioplegia during cardiectomy. Stapling the 
divided aorta of the donor heart facilitates the 
infusion of cardioplegia during implantation. 
Combining the use of cardioplegia during 
20 
Fig. 4. In six dogs. the septal 
temperature decreased more rapidly 
and arrest occurred sooner when 
cardioplegia was used during the 
cardiectomy. 
excision and implantation lessens the need for 
inotropic drugs following transplantation. 
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